Information contained on this page is provided by an independent third-party content provider. Frankly and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact email@example.com
SOURCE Genalyte, Inc.
Founder & CEO Cary Gunn, and President Kevin Lo Available for Meetings, Interviews during J.P. Morgan Healthcare Conference week
SAN DIEGO, Jan. 3, 2018 /PRNewswire/ -- Genalyte, Inc. CEO and founder Cary Gunn will publicly debut the company's state of the art diagnostic testing approach for investors and members of the media in San Francisco, January 7-11, 2018.
Visitors to the patient testing lab station will have the opportunity to personally experience the company's comprehensive blood testing service and rapid results delivery. Genalyte's cloud-based lab model delivers reliable diagnostic results in the physician's office in approximately 15 minutes.
Gunn and newly appointed Genalyte President Kevin Lo will be on-site at the testing suite throughout the week, with availability for media briefings and interviews. Investors and media interested in a testing demonstration or meeting, please contact: firstname.lastname@example.org
Sunday, January 7 – Thursday, January 11
By appointment only
Testing suite is open to press
For a testing demonstration or interviews: email@example.com
Genalyte's mission is to empower doctors and patients to make better decisions that improve outcomes, lower overall costs, and make the diagnostics experience more effective. We employ a cloud-based laboratory service to bring diagnostic testing into the physician's office. Results are returned in approximately 15 minutes, eliminating the need for separate trips to the lab and waiting for results. For more information, please visit: www.genalyte.com.
©2017 PR Newswire. All Rights Reserved.